ArticleCurrent oncology (Toronto, Ont.)2026
Safety of Immune Checkpoint Inhibitors in Hepatitis B Virus-Positive Cancer Patients: A Multicenter Retrospective Cohort Study.
Meshail Baswaid et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.